Search

Search Constraints

You searched for: Author/Creator Papi, Alberto

Search Results

41. Efficacy and safety of once-daily single-inhaler triple therapy (FF/UMEC/VI) versus FF/VI in patients with inadequately controlled asthma (CAPTAIN): a double-blind, randomised, phase 3A trial. Issue 1 (January 2021)

42. Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma: A systematic review for the EAACI Guidelines ‐ recommendations on the use of biologicals in severe asthma. Issue 5 (18th May 2020)

43. Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines ‐ recommendations on the use of biologicals in severe asthma. Issue 5 (24th February 2020)

44. Efficacy and safety of treatment with dupilumab for severe asthma: A systematic review of the EAACI guidelines—Recommendations on the use of biologicals in severe asthma. Issue 5 (1st April 2020)

45. Efficacy and safety of two doses of budesonide/formoterol fumarate metered dose inhaler in COPD. Issue 2 (27th April 2020)

47. Endothelial dysfunction and increased platelet reactivity in patients with acute coronary syndrome and undiagnosed COPD: insights into the SCAP trial. Issue 4 (5th October 2017)

49. ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations. Issue 5 (5th May 2022)

50. ERS/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questions. Issue 3 (28th September 2019)